Compare Adaptive Biotechnologies Corp (ADPT) vs Diageo plc (DEO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Diageo plc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Diageo plc trades at $81.18 (market cap $45.92B). The key difference: Diageo plc is far larger — about 13.8× Adaptive Biotechnologies Corp's market cap, and Diageo plc pays a 4.01% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | DEO | |
|---|---|---|
Market Cap | $3.33B | $45.92B |
Sector | Health | Technology |
52-Week High | $22.37 | $115.33 |
52-Week Low | $10.24 | $72.47 |
Enterprise Value | $3.19B | $66.74B |
Dividend Yield | — | 4.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
